Skip to main content
Clinical Trials/KCT0003612
KCT0003612
Recruiting
未知

Cryoballoon pulmonary vein isolation vs. Cryoballoon pulmonary vein isolation with additional right atrial linear ablation for persistent atrial fibrillation: Prospective randomized trial (CRARAL Trial)

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the circulatory system
Sponsor
Yonsei University Health System, Severance Hospital
Enrollment
330
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient with persistent atrial fibrillation (sustained beyond 7 days) who is scheduled for ablation procedure and \=20 and \=80 years of age
  • 2\. Left atrium size \< 45mm
  • 3\. persistent atrial fibrillation that is reccurrence during antiarrhythmic drug treatment or is not able to use an antiarrhythmic drug.
  • 4\. Patient who is indicated for anticoagulation therapy(for prevention of cerebral infarction)

Exclusion Criteria

  • 1\. Patients with paroxysmal or permanent atrial fibrillation
  • 2\. Atrial fibrillation associated with severe cardiac malformation or a structural heart disease that is hemodynamically affected
  • 3\. Patients with severe renal impairment or CT imaging difficulty using contrast media
  • 4\. Patients with a past history of radiofrequency ablation for atrial fibrillation or other cardiac surgery
  • 5\. Patients with active internal bleeding
  • 6\. Patients with contraindications for anticoagulation therapy(for prevention of cerebral infarction) and antiarrhythmic drugs
  • 7\. Patients with valvular atrial fibrillation (mitral stenosis \>grade 2, mechanical valve, mitral valvuloplasty)
  • 8\. Patients with a severe comorbid disease
  • 9\. Expected survival \< 1 year
  • 10\. Drug addicts or alcoholics

Outcomes

Primary Outcomes

Not specified

Similar Trials